
Triomics raised $15M for its oncology-focused generative AI solutions
Triomics has raised $15 million from a selection of Silicon Valley investors to refine its fine-tuned language models and develop additional software. Triomics models can efficiently match patients with clinical trials and biomarker-driven treatments and extract structured data from health records.